KAPA HyperPETE LC Fusion Panel

Material Number: Select a variation

The KAPA HyperPETE Lung Cancer Fusion Panel is a 18 Kb capture target panel using the novel KAPA HyperPETE technology to detect the known fusions and unknown fusion partners including 17 lung cancer fusion genes and 4 housekeeping genes (as internal controls).

The design and analysis (supported by NAVIFY® Mutation Caller) covers fusions, but the design also covers other variants near the capture region through alternative analysis solutions.

HyperPETE is a primer extension target enrichment technology which combines the ease and speed of an amplicon approach with the quality of target capture. KAPA HyperPETE technology provides a single workday workflow for target enrichment. The integrated end-to-end offering makes for more efficient and effective processes, enabling you to shift your focus to what matters most.

What is PETE?

Features and Benefits of KAPA HyperPETE Catalog Panels

Better by design, using Roche’s renowned content and panel design expertise

  • High uniformity for better sequencing efficiency with less optimization
  • Readily available for fast delivery.

Product highlights

KAPA HyperPETE Catalog Panels enrich with efficiency from cfDNA & FFPE DNA samples

  • Increase your sequencing efficiency with high on-target rates
  • Confidently detect all major variants with broad target coverage at high depth
  • Increase your success and save precious DNA samples, adjusting your input amount by using the KAPA NGS FFPE DNA QC Kit
  • Elevate your detection accuracy using the KAPA Universal UMI Adapter


KAPA HyperPETE Lung Cancer Fusion Panel is intended for use with libraries generated from RNA isolated from tissue FFPE or non-FFPE samples following KAPA HyperPETE Tissue RNA Fusion Transcript workflow IfU.

KAPA HyperPETE Lung Cancer Fusion Panel enables targeted enrichment of a 18KB capture target region of the human genome using the novel PETE technology to detect known/unknown fusions and fusion partners in 17 lung cancer fusion genes (ALK, AXL, BRAF, EGFR, FGFR1, FGFR2, FGFR3, MET, NRG1, NTRK1, NTRK2, NTRK3, PDGFRA, PDGFRB, PPARG, RET, ROS1) and 4 housekeeping genes (RAB7A, VCP, CHMP2A, HPRT1) as positive controls.